Stay updated with breaking news from Michael Esquivel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On April 15, 2024, Fresenius Kabi announced the U.S. launch of its ACTEMRA biosimilar, TYENNE (tocilizumab-aazg) as an intravenous formulation.
In episode 25, Halle and Michael discuss the process of building a board for a startup. They cover topics such as the importance of board structure, when to formalize the board...
In episode 24, Halle and Michael discuss the process of raising a seed round. They cover topics such as when to raise a seed round, building relationships with investors...
In this episode, cancer survivor Kaitlin Christine, the CEO and founder of Gabbi, shares her vision to make all late stage breast cancer obsolete...
You only get to incorporate once, and you want to get it right. In this episode, co-hosts Halle Tecco and Michael Esquivel dive deep into the process of incorporation for startups.